Resumen de acción DPH
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Dechra Pharmaceuticals PLC
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | UK£38.66 |
| 52 Week High | UK£41.46 |
| 52 Week Low | UK£24.73 |
| Beta | 0.78 |
| 1 Month Change | 0.68% |
| 3 Month Change | 1.84% |
| 1 Year Change | 32.40% |
| 3 Year Change | 5.57% |
| 5 Year Change | 60.15% |
| Change since IPO | 2,828.79% |
Noticias y actualizaciones recientes
Recent updates
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt
May 31
A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Mar 28We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt
Mar 02Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125
Mar 02Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Dec 09Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289
Oct 06Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year
Sep 22Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289
Sep 08Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Aug 18Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?
Aug 02These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Jun 10Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)
May 08Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?
Apr 22Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12
Feb 23Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 29Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?
Jan 11Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly
Dec 04It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package
Oct 15Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's
Sep 25Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29
Sep 11With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting
Sep 08Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?
Jun 17Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?
Apr 09Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet
Mar 05Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 17
Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Feb 02Did You Participate In Any Of Dechra Pharmaceuticals' (LON:DPH) Fantastic 268% Return ?
Jan 18Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Jan 03Rentabilidad de los accionistas
| DPH | GB Pharmaceuticals | Mercado GB | |
|---|---|---|---|
| 7D | 0.2% | 5.5% | 1.7% |
| 1Y | 32.4% | 5.6% | 1.4% |
Rentabilidad vs. Industria: DPH superó al sector UK Pharmaceuticals , que obtuvo un rendimiento del -5.5% el año pasado.
Rentabilidad vs. Mercado: DPH superó al mercado UK, que obtuvo un rendimiento del -1.8% el año pasado.
Volatilidad de los precios
| DPH volatility | |
|---|---|
| DPH Average Weekly Movement | 0.5% |
| Pharmaceuticals Industry Average Movement | 9.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Precio estable de las acciones: DPH no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de DPH ha disminuido de 6% a 0% en el último año.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1997 | 2,457 | Ian Page | www.dechra.com |
Resumen de fundamentos de Dechra Pharmaceuticals PLC
| Estadísticas fundamentales de DPH | |
|---|---|
| Capitalización bursátil | UK£4.40b |
| Beneficios(TTM) | -UK£27.90m |
| Ingresos (TTM) | UK£761.50m |
5.8x
Ratio precio-ventas (PS)-157.8x
Ratio precio-beneficio (PE)¿Está DPH sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DPH | |
|---|---|
| Ingresos | UK£761.50m |
| Coste de los ingresos | UK£331.90m |
| Beneficio bruto | UK£429.60m |
| Otros gastos | UK£457.50m |
| Beneficios | -UK£27.90m |
Últimos beneficios comunicados
Jun 30, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.24 |
| Margen bruto | 56.42% |
| Margen de beneficio neto | -3.66% |
| Ratio deuda/patrimonio | 64.6% |
¿Cómo se ha desempeñado DPH a largo plazo?
Ver rendimiento histórico y comparativa